Nevada Mother-To-Child HIV Prevention Program Faces Funding Cuts
Main Category: HIV / AIDSAlso Included In: Women's Health / Gynecology; Pediatrics / Children's Health
Article Date: 15 Apr 2009 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Nevada state officials recently announced plans to terminate funding for the University of Nevada School of Medicine's Nevada Care Program, which largely works to prevent mother-to-child HIV transmission through targeted antiretroviral therapy, the AP/Nevada Appeal reports. According to the officials, Nevada faces a possible $1.2 million funding shortfall for HIV/AIDS-related programs in 2010. Therefore, the state Department of Health and Human Services decided to end the $350,000 Nevada Care Program because of a projected increase in clients and medication costs. According to the AP/Appeal, the Nevada Care Program was the most affected by funding cuts targeting six HIV/AIDS programs in southern Nevada.
According to the AP/Appeal, when the Nevada Care Program began providing MTCT prevention services in 2006, Clark County had four reported HIV cases among infants. However, since the program launched, the county has reported no new cases, although 40 infants have been born to HIV-positive women. Echezona Ezeanolue, director of the Nevada Care Program, said eliminating the program is "a life and death decision that will have consequences far greater than the state has obviously considered." He said, "These children, who would otherwise have a 98% chance to be born without the HIV virus, will more likely be born with the virus." According to Ezeanolue, the budget cuts will not affect the availability of antiretroviral drugs, but they will prevent the program from having office space or medical assistants.
To address the funding shortfall, David Gremse, head of the School of Medicine's pediatric program, recently sent a letter to Rep. Shelley Berkley (D-Nev.) asking for assistance in securing funding to continue the Nevada Care Program. According to Gremse, eliminating funding for the program does not make financial sense. He wrote that by preventing MTCT for 40 infants, the program saved the state $12,124,000 over two years, based on the cost of providing health care for HIV-positive children. According to the AP/Appeal, Berkley has said that she is "hopeful that the financial resources will be found to keep this important program in place" (Harasim, AP/Nevada Appeal, 4/11).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/146111.php>
APA
http://www.medicalnewstoday.com/releases/146111.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



